Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cx601
Cx601
Takeda swoops in to buy stem cell partner TiGenix for $630M, putting it on the threshold of a likely approval
Endpoints
Fri, 01/5/18 - 10:05 am
Takeda
TiGenix
M&A
Crohn’s disease
gene therapy
Cx601
Takeda, TiGenix stem cell therapy shows sustained effect
Fierce Biotech
Sun, 02/19/17 - 12:16 pm
Takeda
TiGenix
stem cells
Cx601
Crohn's Disease